BACKGROUND: Hospitalizations for ambulatory caresensitive conditions (ACSCs), conditions that should not require inpatient treatment if timely and appropriate ambulatory care is provided, may be an important contributor to rising healthcare costs and public health burden. OBJECTIVE: To examine if probable major depression is independently associated with hospitalization for an ACSC in patients with diabetes. DESIGN: Secondary analysis of data from a prospective cohort study. PARTICIPANTS: Population-based cohort of 4,128 patients with diabetes ≥ 18 years old seen in primary care, who were enrolled between 2000 and 2002 and followed for 5 years (through 2007). MAIN MEASURES: Depressive symptoms were assessed with the Patient Health Questionnaire-9. Outcomes of interest included time to initial hospitalization for an ACSC and total number of ACSC-related hospitalizations. We used Cox proportional hazards regression models to ascertain an association between probable major depression and time to ACSC-related hospitalization, as well as Poisson regression for models examining probable major depression and number of ACSC-related hospitalizations. KEY RESULTS: Patients' mean age at study enrollment was 63.4 years (Standard Deviation: 13.4 years). Over the 5-year follow-up period, 981 patients in the study were hospitalized a total of 1,721 times for an ACSC, comprising 45.1 % of all hospitalizations. After adjusting for baseline demographic, clinical and health-risk behavioral factors, probable major depression was associated with initial ACSC-related hospitalization (Hazard Ratio: 1.41, 95 % Confidence Interval [95 % CI]: 1.15, 1.72) and number of ACSC-related hospitalizations (Relative Risk: 1.37, 95 % CI: 1.12, 1.68). CONCLUSIONS: Probable major depression in patients with diabetes is independently associated with hospitalization for an ACSC. Additional research is warranted to ascertain if effective interventions for depression in patients with diabetes could reduce the risk of hospitalizations for ACSCs and their associated adverse outcomes.
INTRODUCTION
The increasing prevalence of type 2 diabetes is causing a public health crisis in the United States. With the aging of the population, the prevalence of diabetes among American adults is expected to increase from 14 % to 33 % by 2050. 1 Among adults ages 65 or older, eight in ten may either have diabetes or prediabetes. 2 Diabetes is known to account for substantial morbidity, disability and mortality, [2] [3] [4] [5] and is also a major driver of exploding healthcare costs. 6 Hospitalization costs are responsible for approximately 50 % of all healthcare costs attributable to diabetes. 6 A substantial proportion of hospitalizations in older adults with diabetes may be preventable because they are for ambulatory caresensitive conditions (ACSCs), 7, 8 which are defined as diagnoses that should not require inpatient treatment if timely and appropriate ambulatory care is provided (e.g., pneumonia, exacerbations of chronic conditions). 9 Recent studies have identified that psychosocial factors such as race, socioeconomic status and mental disorders may increase the risk of hospitalizations for ACSCs. 7, [10] [11] [12] [13] Of the potential psychosocial risk factors for hospitalizations for ACSCs identified, mental disorders represent an area that could be amenable to intervention, and thus may reduce the number and cost of potentially preventable hospitalizations.
In patients with diabetes seen in ambulatory care settings, major depression is the most prevalent mental disorder encountered, occurring in up to 20 % of patients. 14 To date, only two studies have ascertained if depression is associated with greater risk of hospitalization for an ACSC among patients with diabetes, 7, 13 of which one identified depression diagnosis as a potential risk factor. 7 However, neither study was primarily designed to examine potential associations between major depression and risk of hospitalization for an ACSC, and both relied on administrative claims data to identify depression cases, which likely underestimated the potential effect of depression due to under-ascertainment. 13 The present study utilizes a prospective population-based cohort investigation to examine if probable major depression is independently associated with hospitalization for an ACSC, as well as number of ACSC-related hospitalizations in patients with diabetes. We hypothesized that probable major depression in patients with diabetes would be associated with initial hospitalization for an ACSC, even after adjusting for baseline demographic, clinical and health-risk behavioral factors.
METHODS

Population and Setting
Our study is a secondary analysis of data from the Pathways Epidemiologic Study, a prospective cohort study examining the potential adverse impact of major depression in primary care patients with diabetes. Details of the Pathways Epidemiologic Study cohort and setting have been described elsewhere. 15 Briefly, patients with diabetes from nine Group Health Cooperative (GHC) primary care clinics were selected for the study, based on enrollment in the Group Health Diabetes Registry and previously described eligibility criteria, 16 as well as the following three criteria: 1) clinics with the largest populations of patients with diabetes; 2) clinics located within a 40-mile geographic radius of Seattle; and 3) clinics with the greatest amount of ethnic and racial diversity. The study protocol was reviewed and approved by institutional review boards at the University of Washington and GHC.
The cohort was initially sampled between 2000 and 2002 and followed for 5 years through 2007. Permission to review medical records was obtained for 4,128 patients enrolled in the original Pathways study. Non-consenting patients were more often younger, female, non-white, less educated, had a shorter duration of diabetes, a lower mean body mass index (BMI), a lower mean glycosylated hemoglobin (Hb A1c ), and had less medical comorbidity. 15 
Primary Independent Variable
The primary independent variable of interest in our analyses was probable major depression as ascertained by the Patient Health Questionnaire-9 (PHQ-9), 17 which was obtained from a mailed baseline survey. Patients with a PHQ-9 score ≥ 10 with ≥ 5 symptoms (with one of the symptoms being either depressed mood or anhedonia) scored as being present for half of the days or more for at least 2 weeks have probable major depression. A meta-analysis of 14 studies found that the PHQ-9 threshold for a probable case of major depression had a pooled sensitivity of 80 % and specificity of 92 % compared to structured psychiatric interviews. 18 We also examined probable minor depression (defined as the presence of two to four depressive symptoms, one of which is either depressed mood or anhedonia, for more than half the days for at least 2 weeks) as a comparison condition, since prior studies have found minor depression was associated with increased healthcare costs, rehospitalization, and mortality in patients with chronic medical illnesses. [19] [20] [21] The sensitivity and specificity of the PHQ-9 for identifying a probable case of minor depression compared to structured psychiatric interview has been shown to be 77 % and 86 %, respectively. 22 Importantly, the PHQ-9 has been validated in patients with diabetes.
23,24
Covariates of Interest
Covariates of interest were obtained from the baseline survey, as well as medical record and pharmacy data review. Covariates obtained from the survey included sociodemographic characteristics (e.g., age, sex, race, educational level, marital status and perceived social support), diabetes characteristics (duration of diabetes, initial treatment prescribed, and type of current treatment), as well as questions regarding height and weight (used to compute BMI), smoking status, and physical activity from the Summary of Diabetes Self-Care Questionnaire. 25 Covariates obtained from medical record and pharmacy data review included baseline non-diabetes medical comorbidity measured with the RxRisk, an automated pharmacy-based data model that incorporates 46 medical conditions (e.g., cardiovascular disease, asthma, cancer) and has been validated as an independent predictor of increased healthcare costs; 26 the International Classification of Disease Ninth Revision (ICD-9) diagnostic codes for chronic obstructive pulmonary disease (COPD) (which is not included in the RxRisk); number of diabetes complications based on ICD-9 diagnostic codes and laboratory data; 27 the Hb A1c level closest to the baseline survey date; use of oral hypoglycemic agents and/or insulin; one or more hospitalizations in the 2 years prior to study enrollment, and any ICD-9 diagnostic code for alcohol abuse or dependence made in the 2 years prior to study enrollment.
Outcome of Interest
Our outcome of interest was the number of days to an initial hospitalization for an ACSC. We used ICD-9 diagnostic codes to identify hospitalizations for the 16 conditions identified by the Agency for Healthcare Research and Quality as ACSCs in their report on prevention quality indicators (eAppendix available online), 28 as well as hospitalizations for ischemic stroke or transient ischemic attack without concomitant cerebrovascular or cardiovascular procedures, since hospitalizations for these conditions may be potentially preventable if their risk factors (such as prescription of low dose aspirin or antihypertensive medications) are appropriately managed in ambulatory care settings. 29, 30 Hospitalizations were included if the principal discharge diagnosis was for one of the conditions of interest. Time to hospitalization for an ACSC was censored at the end of the study, death, or the time of disenrollment from GHC.
Statistical Analysis
We present descriptive data as means and standard deviations (SDs) or proportions. We examined univariate associations between baseline depression status and demographic, clinical and health-risk behavioral factors using χ 2 tests for categorical variables and one-way analysis of variance for continuous variables.
In order to examine potential associations between probable major or minor depression and time to initial hospitalization for an ACSC, we used Cox proportional hazards regression models. These models estimated the hazard ratio (HR) and 95 % confidence intervals (95 % CIs) for hospitalization for an ACSC. First, we tested the association of baseline probable major or minor depression with time to first hospitalization for an ACSC without adjustment, using the group without baseline clinical depressive symptoms as the reference group. We then sequentially adjusted for our covariates of interest in three groups: 1) demographic and social characteristics (i.e., age, sex, race, education, marital status, perceived social support); 2) clinical factors (i.e., RxRisk scores categorized into quartiles, number of diabetes complications, COPD diagnosis, baseline Hb A1c , duration of diabetes, diabetes treatment intensity (treatment with diet alone, oral hypoglycemic medications and/or insulin) and having one or more hospitalizations in the 2 years prior to enrollment); and 3) health-risk behaviors (i.e., BMI, smoking, lack of exercise and baseline alcohol abuse diagnosis). This fully adjusted model was our a priori primary outcome of interest. We also examined whether our results were affected by adjusting for the continuous number of hospitalizations in the 2 years prior to enrollment. We tested the proportionality assumption of each of the proportional hazards models using Schoenfeld residuals and found that none of the models were in violation.
Our primary cause-specific analyses assume that hospitalization for an ACSC, non-ACSC hospitalization, death, psychiatric hospitalization or disenrollment from GHC are all independent events. However, if these outcomes are all positively correlated, then removing individuals with other events from the risk set could systematically remove individuals at greater risk for the outcome of interest. Therefore, in a pre-specified sensitivity analysis, we examined whether there were competing risks for hospitalization for an ACSC, including non-ACSC hospitalization, death, psychiatric hospitalization and disenrollment from GHC using separate competing-risks regression models according to the Fine and Gray approach. 31 Competingrisks regression models were implemented using stcrreg in STATA 11 (Stata Corporation, College Station, TX).
In order to examine potential associations between probable major or minor depression and number of ACSC-related hospitalizations, we used Poisson regression models with robust error variances. These models estimated the relative risk (RR) and 95 % CIs of an increasing number of ACSC-related hospitalizations. These analyses were conducted similarly to our Cox models. In our final Poisson model, we adjusted for time to death or disenrollment from GHC since patients with baseline probable major depression died or disenrolled from GHC sooner than those without depression.
We used two-sided significance tests for all analyses, with statistical significance set at P=0.05. Analyses were performed with appropriate components of the IBM SPSS Statistics 18 (SPSS Inc., Chicago, IL) and STATA 11 statistical software programs.
RESULTS
A total of 4,128 patients with diabetes were enrolled in the Pathways Epidemiologic Study (Fig. 1) . Table 1 describes the baseline demographic, clinical and health-risk behavioral characteristics of study participants grouped by depressive symptom status. At baseline, 12.0 % of patients reported probable major depression, while 8.3 % of patients reported probable minor depression. Their mean age at study enrollment was 63.4 years (SD: 13.4 years). At the time of enrollment, patients were living with diabetes for a mean of 9.6 years (SD: 9.4 years) and had a mean of 1.8 diabetes complications (SD: 2.0 complications). Patients with probable major depression at baseline had a mean PHQ-9 score of 17.2 (SD: 3.9), while patients with probable minor depression had a mean PHQ-9 score of 9.6 (SD: 2.2).
Over the 5 year follow-up period, 981 patients in the study were hospitalized a total of 1,721 times for an ACSC, comprising 45.1 % of all hospitalizations. Nearly one in three (150 of 495) patients with diabetes and probable major depression were hospitalized for an ACSC, compared to one in four (84 of 343) with probable minor depression and nearly one in four (747 of 3,279) without clinically noticeable depressive symptoms (χ 2 =13.50, degrees of freedom=2, P=0.001). Table 2 displays the unadjusted and adjusted associations between symptoms of probable major depression and first hospitalization for an ACSC. In patients with diabetes, probable major depression was consistently independently associated with hospitalization for an ACSC over the 5-year follow-up period (Fig. 2) . The association between probable major depression and hospitalization for an ACSC remained unchanged when we adjusted for the continuous number of hospitalizations in the 2 years prior to enrollment (Adjusted HR [AHR]: 1.41, 95 % CI: 1.15, 1.72). Probable minor depression was not associated with days to a hospitalization for an ACSC in any of our models.
Covariates that were significantly associated with hospitalization for an ACSC included increased age, medical comorbidity (including COPD diagnosis), number of diabetes complications, Hb A1c , one or more hospitalizations in the 2 years prior to enrollment, and lack of exercise. In our competing-risks regression sensitivity analyses, probable major depression remained independently associated with hospitalization for an ACSC even when accounting for the competing risks of hospitalization for a non-ACSC (n=751), death (n=655), psychiatric hospitalization (n=57), or disenrollment from GHC (n=642) ( Table 3 ).
In addition, baseline probable major depression, but not probable minor depression, was associated with number of hospitalizations for an ACSC in unadjusted and adjusted models. In our fully adjusted Poisson model, probable major depression was associated with a 37 % greater risk (Relative Risk: 1.37, 95 % CI 1.12, 1.68) of an additional hospitalization for an ACSC (eTable available online).
DISCUSSION
In this prospective cohort of patients with diabetes, we found that probable major depression was independently associated with an approximately 40 % greater risk of hospitalization for an ACSC and a greater number of ACSC-related hospitalizations. Importantly, this association remains robust even when taking into account prior hospitalizations, as well as other indicators of greater patient complexity that could also increase the risk of ACSC-related hospitalization, such as increased age, greater medical comorbidity, poor glucose control and history of alcohol abuse. 32, 33 Since hospitalization for an ACSC implies a breakdown in the quality of, and/or access to, primary care, 7,10 our findings suggest that patients with comorbid diabetes and probable major depression may represent a population at particular risk for the declining health status that an ACSC-related hospitalization indicates. 34 Similar to other chronic medical illnesses, diabetes and comorbid mental disorders such as major depression are bidirectionally related. 35 Major depression is associated with behavioral risk factors for diabetes such as obesity and sedentary lifestyle, as well as psychobiologic risk factors such as increased cortisol levels and increased inflammatory factors. 35 These behavioral and psychobiologic factors increase risk of development of diabetes, and the poor self-care associated with depression can lead to subsequent macrovascular and microvascular complications that can ultimately cause or exacerbate depressive illness. 35 In support of this model, a systematic review has found that major depression is a significant risk factor for diabetes, and diabetes in turn is also a significant risk factor for subsequent development of depression; 36 depression has also been found to be associated with poor glycemic control in patients with diabetes and greater risk of macrovascular and microvascular complications, 37, 38 factors that could increase the risk of hospitalization.
Hospitalizations for ACSCs could compound the adverse effects of depression in patients with diabetes. Prior studies have identified that major depression in patients with diabetes is associated with increased risk of dementia, 15, 39 and a growing body of research is identifying that hospitalizations for medical illnesses are independently associated with cognitive decline in older adults. [40] [41] [42] [43] Taking into account the high prevalence and frequent comorbidity of depression, diabetes and dementia, additional studies are needed to test interventions aimed at reducing hospitalizations for ACSCs in patients with diabetes that utilize successful elements from existing strategies for depres- sion. 44 Such interventions could have the potential to prevent cognitive decline and enduring disability in this high-risk population.
An additional area of concern emphasized by our findings is the potential impact on healthcare costs due to ACSC-related hospitalizations in older adults with diabetes and comorbid depression. For a single patient, diabetes and its complications account for up to $3,225 of excess medical costs per hospital day, 6 and patients with diabetes and comorbid depression have increased healthcare costs relative to patients with diabetes alone. 45 The increasing healthcare costs due to potentially preventable hospitalizations in older adults with diabetes have led healthcare systems to identify ways to predict patients at risk for greater costs. 46, 47 Our models found that probable major depression, increased age, greater medical comorbidity and severity of diabetes complications, as well as lack of exercise, all had potent independent associations with ACSC-related hospitalizations, suggesting that these factors could comprise key elements of a prediction model to identify older patients with diabetes at risk for higher healthcare costs that could be validated in additional at-risk populations.
Our study does have several potential limitations. Since a substantial number of patients eligible for the Pathways Epidemiologic Study either did not return a baseline survey or did not consent for medical record review, we cannot rule-out the possibility of nonresponse bias affecting our results, and we are unable to quantify the extent of this potential bias since we lack baseline data for subjects who did not return surveys. Although our ability to diagnose major depression was limited by our use of a questionnaire to assess depressive symptoms and not a diagnostic interview, the questionnaire we used has been validated in our study population and has acceptable sensitivity and specificity compared to structured diagnostic interview. 17, 18 Also, self-report of baseline factors such as physical inactivity, smoking, and BMI may not accurately reflect subsequent health behaviors over the follow-up period. Though we only measured depression at baseline and depression status may have changed over the course of follow-up, a related study in patients with diabetes found that over 70 % of patients with a PHQ-9 score ≥ 10 reported that they had been depressed for more than 2 years. 48 In addition, because over 20 % of our sample did not respond to the question regarding income, we did not include this variable in our analyses; however, educational level is an acceptable proxy for socioeconomic status. Further, we are unable to be certain that every hospitalization that an enrolled subject had during the study period was captured within our available data. Although the potential generalizability of this study may be limited by having been conducted in a single healthcare system, it is important to note that GHC had implemented programmatic interventions to reduce hospitalizations during the 5-year follow-up period, 49, 50 suggesting that the magnitude of the association we found between probable major depression and hospitalizations for ACSCs-could be even greater. Finally, the possibility of residual confounding remains as in any observational study.
In conclusion, we found that probable major depression in patients with diabetes was independently associated with risk of hospitalizations for ACSCs. Since major depression is amenable to treatment, future research should seek to ascertain if effective interventions for depression in patients with diabetes could reduce the risk of hospitalizations for ACSCs and their associated adverse outcomes.
